β-Caryophyllene-d2

CAT:
804-HY-N1415S
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
β-Caryophyllene-d2 - image 1

β-Caryophyllene-d2

  • Description:

    β-Caryophyllene-d2 is deuterium labeled β-Caryophyllene. β-Caryophyllene is a CB2 receptor agonist.
  • UNSPSC:

    12352211
  • Target:

    Cannabinoid Receptor; Endogenous Metabolite
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Cancer; Infection; Neurological Disease
  • Purity:

    94.22
  • Solubility:

    10 mM in DMSO|DMSO : 50mg/mL (ultrasonic; warming; heat to 60°C) |Ethanol : ≥ 176.67mg/mL|H2O : 0.67mg/mL (ultrasonic)
  • Smiles:

    CC1([C@@]2([H])[C@](/C(CC/C=C(CC2)/C)=C([2H])\[2H])([H])C1)C
  • Molecular Formula:

    C15H22D2
  • Molecular Weight:

    206.36
  • References & Citations:

    [2]Cheng Y, et al. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway. Pharmacology. 2014;94 (1-2) :1-12.|[3]Dahham SS, et al. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllenefrom the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26;20 (7) :11808-29.|[4]de Oliveira CC, et al. Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures. Epilepsy Behav. 2016 Mar;56:26-31.|[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, protect from light)
  • Scientific Category:

    Isotope-Labeled Compounds
  • Clinical Information:

    No Development Reported
  • CAS Number:

    2006272-96-2